Infographic: Infliximab Biosimilars in the United States

Where does the market for infliximab stand in the United States? Our infographic provides a brief history of Remicade and its biosimilars.

Related Content:

Rheumatology

Alvotech Snags Australian Approval for Adalimumab Biosimilar

Contributor: What Is the Value of the Interchangeability Designation for a Biosimilar?

Eye on Pharma: Natalizumab Injunction; Oral Ustekinumab Development; New Study for Secukinumab Biosimilar